⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Effect of Azeliragon Combined With Stereotactic Radiation Therapy in Patients With Brain Metastases

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Effect of Azeliragon Combined With Stereotactic Radiation Therapy in Patients With Brain Metastases

Official Title: A Phase I/II Study to Assess Safety and Preliminary Evidence of a Therapeutic Effect of Azeliragon Combined With Stereotactic Radiation Therapy in Patients With Brain Metastases

Study ID: NCT05789589

Study Description

Brief Summary: To determine the safety and efficacy of using the drug azeliragon combined with stereotactic radiosurgery. Specifically, to determine if this combination will lead to improved response in the brain (tumor shrinking in size) and overall tumor control (how long tumor remains controlled).

Detailed Description:

Keywords

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Miami Cancer Institute at Baptist Health, Inc., Miami, Florida, United States

Contact Details

Name: Minesh Mehta, M.D.

Affiliation: Miami Cancer Institute at Baptist Health, Inc.

Role: PRINCIPAL_INVESTIGATOR

Name: Yazmin Odia, M.D.

Affiliation: Miami Cancer Institute at Baptist Health, Inc.

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: